Getting phage research funded — Joe Campbell reflects on a career at NIAID episode artwork

EPISODE · Aug 8, 2024 · 46 MIN

Getting phage research funded — Joe Campbell reflects on a career at NIAID

from Podovirus · host Jessica Sacher and Joseph Campbell

Welcome to the Podovirus podcast, episode 2! In this episode, Jessica talks with Dr. Joe Campbell, who recently retired as a program officer at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Joe played a key role in shaping phage research funding and policy during his tenure at NIAID. He reflects on his career, the evolution of phage therapy research, and shares insights into the grant application process. Takeaways - Phage therapy funding at NIAID has evolved over time; it used to be lumped in with antibiotics, but Joe and his colleague Jane Knisely at NIAID eventually spearheaded the creation of phage-specific grants, which had phage people on their study sections! - Phage therapy centers, such as Phage Canada and Phage Australia, play a key role nowadays in providing personalized phage treatments for patients who don't fit the criteria for traditional clinical trials. - Rigorous clinical trials are essential for demonstrating the efficacy of phage therapies and gaining support from governments and healthcare systems. - Phage therapy has the potential to treat a wide range of infections, and Joe is optimistic that clinical trials will show positive results Chapters 00:00 Introduction 01:24 Reflections on a Career in the Phage Field 06:18 The Evolution of Phage Therapy Funding at NIAID 10:53 Taking Action to Support Phage Grants 14:09 The Impact of Phage Grants on Research and Funding 20:41 The Role of Phage Therapy Centers 22:47 Balancing Phage Therapy Centers and Biotech Companies 28:25 Challenges in Developing Phage Therapies in the US Healthcare System 30:41 The Importance of Rigorous Clinical Trials for Phage Therapies 33:38 NIAD's Preclinical Services for Phage Therapy Development 34:57 Pseudomonas Mouse Models and In Vitro Assays 37:09 The Role of NIAD Program Officers 38:46 Addressing the Economic Challenges of Phage Therapy

Episode metadata supplied by the publisher feed · Published Aug 8, 2024

Welcome to the Podovirus podcast, episode 2! In this episode, Jessica talks with Dr. Joe Campbell, who recently retired as a program officer at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Joe played a key role in shaping phage research funding and policy during his tenure at NIAID. He reflects on his career, the evolution of phage therapy research, and shares insights into the grant application process. Takeaways - Phage therapy funding at NIAID has evolved over time; it used to be lumped in with antibiotics, but Joe and his colleague Jane Knisely at NIAID eventually spearheaded the creation of phage-specific grants, which had phage people on their study sections! - Phage therapy centers, such as Phage Canada and Phage Australia, play a key role nowadays in providing personalized phage treatments for patients who don't fit the criteria for traditional clinical trials. - Rigorous clinical trials are essential for demonstrating the efficacy of phage therapies and gaining support from governments and healthcare systems. - Phage therapy has the potential to treat a wide range of infections, and Joe is optimistic that clinical trials will show positive results Chapters 00:00 Introduction 01:24 Reflections on a Career in the Phage Field 06:18 The Evolution of Phage Therapy Funding at NIAID 10:53 Taking Action to Support Phage Grants 14:09 The Impact of Phage Grants on Research and Funding 20:41 The Role of Phage Therapy Centers 22:47 Balancing Phage Therapy Centers and Biotech Companies 28:25 Challenges in Developing Phage Therapies in the US Healthcare System 30:41 The Importance of Rigorous Clinical Trials for Phage Therapies 33:38 NIAD's Preclinical Services for Phage Therapy Development 34:57 Pseudomonas Mouse Models and In Vitro Assays 37:09 The Role of NIAD Program Officers 38:46 Addressing the Economic Challenges of Phage Therapy

PodParley-generated summary based on available episode metadata and transcript content.

NOW PLAYING

Getting phage research funded — Joe Campbell reflects on a career at NIAID

0:00 46:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Podovirus?

This episode is 46 minutes long.

When was this Podovirus episode published?

This episode was published on August 8, 2024.

What is this episode about?

Welcome to the Podovirus podcast, episode 2! In this episode, Jessica talks with Dr. Joe Campbell, who recently retired as a program officer at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of...

Can I download this Podovirus episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!